whats the point of paying for a research note if they dont provide a valuation/target price?the least they could do is show how ZYL is valued relative to its peers
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025